Supernus Pharmaceuticals, Inc. (SUPN)
37.88
-1.69
(-4.27%)
USD |
NASDAQ |
Oct 16, 16:00
37.86
-0.02
(-0.05%)
After-Hours: 20:00
Supernus Pharmaceuticals Free Cash Flow (Quarterly) : -5.378M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.378M |
| March 31, 2026 | 66.52M |
| December 31, 2025 | 19.43M |
| September 30, 2025 | -61.79M |
| June 30, 2025 | 58.08M |
| March 31, 2025 | 30.27M |
| December 31, 2024 | 44.19M |
| September 30, 2024 | 53.32M |
| June 30, 2024 | 35.56M |
| March 31, 2024 | 38.15M |
| December 31, 2023 | 44.99M |
| September 30, 2023 | 35.72M |
| June 30, 2023 | -19.03M |
| March 31, 2023 | 48.85M |
| December 31, 2022 | 27.57M |
| September 30, 2022 | 13.69M |
| June 30, 2022 | 71.70M |
| March 31, 2022 | 3.451M |
| December 31, 2021 | 48.72M |
| September 30, 2021 | -4.154M |
| June 30, 2021 | 46.27M |
| March 31, 2021 | 34.24M |
| December 31, 2020 | 31.62M |
| September 30, 2020 | 5.32M |
| June 30, 2020 | 91.39M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.379M |
| December 31, 2019 | 41.76M |
| September 30, 2019 | 37.20M |
| June 30, 2019 | 28.66M |
| March 31, 2019 | 32.77M |
| December 31, 2018 | 32.62M |
| September 30, 2018 | 61.98M |
| June 30, 2018 | 6.194M |
| March 31, 2018 | 26.54M |
| December 31, 2017 | 34.56M |
| September 30, 2017 | 37.68M |
| June 30, 2017 | 19.57M |
| March 31, 2017 | 9.65M |
| December 31, 2016 | 18.04M |
| September 30, 2016 | 19.30M |
| June 30, 2016 | 12.90M |
| March 31, 2016 | -3.857M |
| December 31, 2015 | 15.06M |
| September 30, 2015 | -1.668M |
| June 30, 2015 | 10.27M |
| March 31, 2015 | -2.149M |
| December 31, 2014 | 5.52M |
| September 30, 2014 | 25.58M |
| June 30, 2014 | -8.042M |
| March 31, 2014 | -20.42M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 221.58M |
| Prestige Consumer Healthcare, Inc. | 67.08M |
| Pfizer Inc. | 302.00M |
| Amphastar Pharmaceuticals, Inc. | 42.73M |
| Bristol Myers Squibb Co. | 3.088B |